Demographic factors and age in particular were more consistent predictors of school functioning than disease factors. Special attention to older youth and those with active disease may be important to ensure optimal school functioning.

People with type 1 diabetes (T1D) often experience significant sleep disturbances related to the demands of T1D management, symptoms of glucose variability and diabetes-related stress. 1,2 Models of sleep in people with T1D demonstrate bi-directional associations between poor sleep (i.e., low sleep quality and duration) and glycaemic outcomes, including insulin resistance and glucose intolerance. 3 Additionally, disrupted sleep negatively impacts one's ability to complete complex diabetes tasks further impacting glycaemic outcomes. 4 Children, adolescents and young adults with T1D demonstrate poorer sleep quality, more disrupted sleep, and shorter sleep duration than those without diabetes. 5 Adolescents and young adults with T1D report sleeping less than the recommended 8-10 h a night, with an average self-report of 7 h of sleep per night. 6 Qualitative studies in

Objective The current study explored pre‐pandemic sociodemographics, medical characteristics, social/family support, and mood symptoms, and current COVID‐19 experiences as predictors of mood, positive/negative diabetes‐specific experiences, and COVID‐19‐specific distress among parents of children with type 1 diabetes during the COVID‐19 pandemic. We hypothesized that parents from marginalized backgrounds, youth with higher pre‐pandemic A1c and no CGM use, parents with lower pre‐pandemic social/family support and more pre‐pandemic mood/anxiety symptoms, and those with more negative COVID‐19 experiences would have more depressive symptoms, fewer positive and more negative diabetes‐specific experiences, and more COVID‐19‐specific distress during the initial months of the pandemic. Research Design and Methods Participants were parents of early school‐age children with type 1 diabetes (n = 100; 65% non‐Hispanic, white, 92% mothers, 75% married; Mchild age = 6.74 ± 1.59 years) who had completed a behavioral intervention trial ≥6 months ago and were re‐contacted in June/July 2020 to report on their COVID‐19 pandemic experiences and parent psychosocial outcomes. Pre‐pandemic parent mood/anxiety symptoms, family/social support, and children's medical characteristics (CGM use; MA1C = 8.17% ± 1.40%) were assessed M = 1.45 ± 0.59 years prior. Results More pre‐pandemic social support predicted fewer depressive symptoms, more positive diabetes‐specific experiences, and less COVID‐19‐specific distress during the pandemic. More pre‐pandemic depressive symptoms predicted more depressive symptoms during the pandemic. More life disruptions due to the pandemic were associated with more negative diabetes‐specific experiences and more COVID‐19‐specific distress. Parents of color had more negative diabetes‐specific experiences. Conclusions Social support may be particularly important to assess and address through intervention. Pediatric diabetes care providers should monitor parent experiences in relation to children's diabetes management. ClinicalTrials.gov identifier: NCT02527525.